crown slocum realty, inc.

54 grove street
tarrytown, new york 10591

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 15, 2013

NYS DOS ID#
4487788

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - CROWN SLOCUM REALTY, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Supreme Court to hear case that may muffle whistleblowers
    By Kevin Dugan - Tuesday Jun 27, 2017

    The Supreme Court said on Monday it will weigh in on the limits of whistleblower protections that are part of Obama-era Dodd-Frank financial reform law — potentially weakening protections for people who report wrongdoing in corporate America. The high court will hear Digital Realty Trust Inc.’s case against Paul Somers, an executive fired by the...

    Source: New York Post: Business
  • HP Takes Back PC Crown From Lenovo in Second Quarter
    Wednesday Jul 12, 2017

    HP Inc. has taken back the crown from rival Lenovo Group Ltd. as the top seller of personal computers, ending the Chinese company’s four-year reign, according to data from research firm Gartner.

    Source: The Wall Street Journal: Technology: What's News
  • Get ready for 'spring cleaning' in foreclosures
    By podcast@wsj.com (MarketWatch.com) - Thursday Dec 11, 2014

    RealtyTrac sees foreclosures at pre-recession levels early next year, and banks gearing up for some "spring cleaning."

    Source: The Wall Street Journal: MarketWatch News Break
  • Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
    By Ben Fidler - Monday Sep 11, 2017

    A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]

    Source: Xconomy New York
  • A Designer With a Low Profile Is Ready to Raise It Up
    By MATTHEW SCHNEIER - Wednesday Sep 27, 2017

    Before the LVMH Prize crowned her the next big thing, few had heard of Marine Serre. That’s about to change.

    Source: NYT > Home Page